Goodman Noah

Chief Business Officer

Goodman Noah has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.

On the most recent filing, Goodman Noah is listed as Chief Business Officer at Kymera Therapeutics, Inc. Inside the rolling window, Goodman Noah reported no open-market purchases and 6 open-market sales totaling $2.2M in KYMR. The largest disclosed transaction in the window is a sale of 8,264 KYMR shares on Apr 9, 2026, worth $723K.

Companies traded

Other insiders at KYMR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$2.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KYMRSale$387KJul 2SEC ↗
KYMRSale$570KJun 25SEC ↗
KYMRSale$248KJun 22SEC ↗
KYMRSale$121KApr 16SEC ↗
KYMRSale$723KApr 10SEC ↗
KYMRSale$175KApr 10SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Goodman Noah made?

Goodman Noah has filed 6 SEC Form 4 filings (13 transaction rows) across 1 company since 2026.

Which companies does Goodman Noah trade?

Goodman Noah has filed SEC Form 4 disclosures for 1 company, including KYMR.

When was Goodman Noah's most recent SEC Form 4 filing?

Goodman Noah's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.

What is Goodman Noah's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Goodman Noah is listed as Chief Business Officer.

What is Goodman Noah's total buy and sell value in the current window?

Inside the rolling retention window, Goodman Noah bought $0 and sold $2.2M based on SEC Form 4 filings.

What was Goodman Noah's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 8,264 KYMR shares on 2026-04-09, worth $723K, per SEC Form 4 filings.